[A specific protein inhibiting membrane permeation of chloramphenicol in Pseudomonas aeruginosa]

Area of Science:

• Microbiology
• Molecular Biology
• Biochemistry

Background:

• Pseudomonas aeruginosa is an opportunistic pathogen known for its intrinsic and acquired antibiotic resistance.
• Chloramphenicol (CP) resistance in bacteria can be mediated by various mechanisms, including reduced drug uptake.
• Plasmid-mediated resistance, such as that conferred by plasmid kR102, is a significant challenge in treating P. aeruginosa infections.

Purpose of the Study:

• To identify proteins responsible for chloramphenicol (CP) resistance in Pseudomonas aeruginosa.
• To investigate the role of a specific protein in modulating CP permeability.
• To understand the molecular mechanisms underlying impermeability-type CP resistance.

Main Methods:

• Affinity chromatography using chloramphenicol (CP) base was employed to isolate proteins from the periplasmic space of CP-resistant P. aeruginosa.
• Proteins were purified from bacterial strains harboring the plasmid kR102.
• Membrane reconstitution experiments using a liposome system were performed to assess protein function.

Main Results:

• A specific protein with a molecular weight of 18,000 was isolated and identified.
• This protein was found in the periplasmic space of impermeability-type CP-resistant P. aeruginosa.
• Liposome-based reconstitution experiments demonstrated that the purified protein inhibits the permeability of chloramphenicol (CP).

Conclusions:

• A novel 18 kDa protein contributes to chloramphenicol (CP) resistance in Pseudomonas aeruginosa by inhibiting drug permeability.
• The identified protein represents a potential target for developing strategies to overcome CP resistance in P. aeruginosa infections.
• Understanding the role of this protein enhances our knowledge of bacterial drug efflux and resistance mechanisms.